-
Snibe received CE List A Certificate for HBV Detection
Shenzhen, China, 26 May 2022-- Snibe has received the CE List A Certificate for 5 MAGLUMI® CLIA immunoassays of Hepatitis B virus (HBV) detection, covering Anti-HBc IgM, Anti-HBs, HBeAg, Anti-HBe, and anti-HBC. Up to now, 6 CLIA immunoassays for HBV detection have all obtained CE List A Certificate, besides the MAGLUMI® HBsAg (CLIA) Assay. -
Snibe Gets CE Mark for COVID-19 Antigen Self-Testing
Recently, Snibe receives the CE mark for its RapisafeTM SARS-CoV-2 Ag test (Colloidal Gold), which further confirmed that the quality of our Self-Testing kits is in line with international standards. -
Snibe announced a global strategic cooperation with Thermo Fisher Scientific
From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.
-
Snibe Shows Great Charm at Medlab Middle East
Medlab Middle East 2023, one of the world's largest international medical trade fairs, is held at the Dubai International Trade Center, UAE, from February 6–9, 2023. Snibe, as a platinum level sponsor, participated in this international medical event, and shows cutting-edge diagnostic solutions to global visitors. -
Snibe Digital PCR System Launches at MEDICA 2022
MEDICA, known as the leading international trade fair for the medical sector, was held in Dusseldorf, Germany, from November 14th to 17th. Snibe is honored to be part of it and bring its cutting-edge products to the world during MEDICA 2022. -
Snibe Shines at the WorldLab 2022 in Seoul
WorldLab Seoul 2022, the 24th International Congress of Clinical Chemistry and Laboratory Medicine is held at Coex, Seoul, Korea on 26-30 June 2022, which presents and discusses the latest advances in clinical laboratory diagnosis together with global attendees.
